About Erasca (ERAS)
Erasca, Inc is a clinical-stage precision oncology company. The Company is focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. The Company is engaged in oncology and RAS targeting to cr... Read more
- USD1.38
- USD1.46
- USD1.35
- USD3.45
- 16.30%
- --
- 537.40k
- 1.42M
- 448M
- 1.01
- -29.10%
Stock News
2 hours ago
U.S. and China conclude two days of ‘productive’ trade talks, Bessent says
MarketWatch
3 hours ago
Trump poised to accept Qatar jet gift as Air Force One
CNBC
4 hours ago
Here are the 3 things we're watching in the stock market in the week ahead
CNBC
5 hours ago
Invesco Corporate Bond Fund Q1 2025 Commentary
SeekingAlpha
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
